HVIVO PLC
HVO | IL
Overview
Corporate Details
- ISIN(s):
- GB00B9275X97
- LEI:
- 213800VT5KBM7JLIV118
- Country:
- United Kingdom
- Address:
- QUEEN MARY BIOENTERPRISES INNOVATION CENTRE, E1 2AX LONDON
- Website:
- https://hvivo.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
hVIVO PLC is a specialist contract research organization (CRO) and a world leader in human challenge clinical trials for testing infectious and respiratory disease vaccines and therapeutics. The company provides end-to-end services, designing and conducting trials where volunteers are safely exposed to a pathogen to accelerate the evaluation of new medical interventions. Its expertise covers a wide range of well-established challenge models for diseases such as Influenza, RSV, COVID-19, hMPV, and Malaria. Leveraging state-of-the-art quarantine facilities, proprietary viral challenge agents, and comprehensive laboratory services, hVIVO supports a global client base of pharmaceutical and biotechnology companies in fast-tracking the development of their products.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for HVIVO PLC.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-29 08:00 |
Board/Management Information
Proposed appointment of Chair
|
English | 16.3 KB | |
| 2025-07-22 08:00 |
Earnings Release
H1 Trading update
|
English | 26.7 KB | |
| 2025-07-18 08:00 |
Board/Management Information
Directorate Change
|
English | 16.4 KB | |
| 2025-07-09 08:00 |
Report Publication Announcement
Notice of Trading Update
|
English | 17.4 KB | |
| 2025-07-01 17:04 |
Major Shareholding Notification
Holding(s) in Company
|
English | 24.3 KB | |
| 2025-06-30 08:00 |
Earnings Release
Positive results from client Phase 2b field study
|
English | 22.0 KB | |
| 2025-06-05 14:00 |
Post-Annual General Meeting Information
Result of AGM
|
English | 15.3 KB | |
| 2025-06-02 08:00 |
Director's Dealing
Director/PDMR Shareholding
|
English | 48.9 KB | |
| 2025-05-30 08:00 |
Business and Financial Review
Trading update
|
English | 18.7 KB | |
| 2025-05-29 08:00 |
Board/Management Information
Appointment of Independent Non-Executive Director
|
English | 22.6 KB | |
| 2025-03-26 14:51 |
Board/Management Information
AIM Rule 17 and Schedule 2(g) Update
|
English | 15.3 KB | |
| 2025-03-07 08:00 |
Director's Dealing
Director/PDMR Shareholding
|
English | 40.4 KB | |
| 2025-02-27 08:00 |
M&A Activity
Acquisition of Cryostore for up to £3.2m
|
English | 22.4 KB | |
| 2025-02-17 08:00 |
Earnings Release
£2m hMPV characterisation study contract
|
English | 19.3 KB | |
| 2025-02-05 08:00 |
Legal Proceedings Report
Shionogi reports positive RSV trial results
|
English | 19.3 KB |
Automate Your Workflow. Get a real-time feed of all HVIVO PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for HVIVO PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
